Neurostimulation Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Neurostimulation Devices Market By Stimulation System (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation, Percutaneous Electrical Nerve Stimulation (PENS), and Others), Disease Indication (Pain, Neurological Disorders, Sleep Apnea, Bladder and Bowel dysfunction and Others), Charging System (Rechargeable and Non-rechargeable), End-User (Hospitals, Specialty Clinics, and Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The global neurostimulation devices market size valued at $5.47 billion in 2021 and expected to reach $10.96 billion in 2028, growing at a CAGR of 11.8% during the forecast period 2022-2028. For the treatment of chronic pain, movement problems, epilepsy, and Parkinson’s disease, neurostimulation devices administer electrical stimulation to specific regions of the patient’s brain, spinal cord, or peripheral nervous system. Spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and cortical stimulators are among the neurostimulation devices. High cost, device malfunctions, and stringent regulatory policies are projected to restrain the growth of the market over the forecast period. For instance, in February 2014, TGA gave hazard alert to Medtronic’s deep brain and spinal cord stimulation systems due to unexpected loss of stimulation and over-stimulation of the devices in the Australia. This report studies neurostimulation devices market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, neurostimulation devices market report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed neuromodulation devices market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Neurostimulation Devices Market

MARKET SUMMARY
-
11.8% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 11.8%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Neurostimulation Devices Market

  • The report on neurostimulation devices market gives historical, current, and future market sizes (US$ Bn) of stimulation system, disease indication, charging system, end-user, and geographic regions.
  • neurostimulation devices market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • Key stakeholders of the neuromodulation devices market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of neurostimulation devices.
Key Players
  • Abbott Laboratories
  • Axonics Modulation Technologies
  • BioControl Medical
  • Bioness Inc.
  • Biowave Corporation
Neurostimulation Devices Market Drivers And Restraints

Rise in adoption of novel devices such as neurostimulation devices in the management of various diseases: pain, neurological disorders, obesity, and sleep apnea, among others over conventional drug treatments are projected to create significant opportunities for the neurostimulation device manufacturers. Currently, few ailments like parkinson’s, epilepsy, and urinary incontinence conditions have limited treatment options. Hence, neurostimulation devices became an alternative treatment method to treat aforementioned conditions. Furthermore, increase in incidence and prevalence of pain and neurological disorders are projected to drive the growth of the neurostimulation devices market over the forecast period. Increase in costs to manage pain conditions are creating burden on healthcare system. As per the estimates of research article published in Institute of Medicine (IOM) in 2011, the annual health care costs due to pain management is at least US$ 560-635 Bn annually in the U.S. In addition, lack of side effects for the neuromodulation devices are fuelling the growth of the neurostimulation devices market.


North-America Got Significant Share

Neurostimulation Devices Market

North America dominates the global neurostimulation devices market in terms of revenue in 2019 owing to active investments by venture capitalists in the neurostimulation device start-ups that are working on novel application areas. For instance, Johnson & Johnson Development Corporation, a venture capital arm of Johnson and Johnson Services Inc., invested in three start-ups that are based out in United States: Nevro Corp., NeuroPace, Inc., and CVRx. Regions such as Asia-Pacific projected to create significant opportunities for neurostimulation devices market in the forecast period owing to increase in adoption of neurostimulation devices.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • Based on stimulation system, Spinal Cord Stimulation system (SCS) accounted for larger market share in 2019 owing to as many government bodies are promoting medication free pain treatments in order to reduce dependency on opioid and non-opioid medications.
  • Neurological disorders segment projected to be most lucrative market in global neurostimulation devices market due to global increase in prevalence and incidence of neurological disorders
  • Rechargeable devices segment projected to dominate over the forecast period as they don’t require surgical intervention to replace batteries
  • Hospitals are the main end-user for neurostimulation devices across the globe
  • Players focusing on development of new products for various therapeutic applications
Neurostimulation Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The neurostimulation devices market is projected to expand at a CAGR of 11.8% during the forecast period

 

 

Abbott Laboratories, Axonics Modulation Technologies, BioControl Medica, Bioness Inc, Biowave Corporation

North America is the fastest-growing region for  The neurostimulation devices market

 


Report

Table Of Content

  1. Executive Summary
  2. Global Neurostimulation Devices Market Introduction
    • Global Neurostimulation Devices Market – Taxonomy
    • Global Neurostimulation Devices Market–Definitions
      • Application
      • Product Type
      • Device Type
      • End User
      • Region
  1. Global Neurostimulation Devices Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Neurostimulation Devices Market Dynamics – Factors Impact Analysis
    • Global Neurostimulation Devices Market Dynamics – Regulations
      • US
      • Europe
      • Japan
      • China
    • Global Neurostimulation Devices Market– Product Innovations
  2. Global Neurostimulation Devices Market Analysis 2020 – 2026
    • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Neurostimulation Devices Market, By Application, 2020 – 2026
    • Management of Pain
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Parkinson’s Disease
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Epilepsy
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Gastroparesis
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Tremors
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Urinary & Fecal Incontinence
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Depression
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Dystonia
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
  1. Global Neurostimulation Devices Market , By Product Type, 2020 – 2026
    • Deep Brain Stimulators (DBS)
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  1. 2.3. Market Opportunity Analysis
    • Gastric Electric Stimulators (GES)
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Spinal Cord Stimulators (SCS)
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  1. 2.3. Market Opportunity Analysis
    • Sacral Nerve Stimulators (SNS)
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  1. 2.3. Market Opportunity Analysis
    • Vagus Nerve Stimulators (VNS)
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
  1. Global Neurostimulation Devices Market Forecast, By Device Type, 2020 – 2026
    • Invasive Devices
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Non-Invasive Devices
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
  1. Global Neurostimulation Devices Market Forecast, By End User, 2020 – 2026
    • Hospitals
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Ambulatory Surgical Centers
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Neuro Clinics
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
  1. Global Neurostimulation Devices Market Forecast, By Region, 2020 – 2026
    • North America
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Europe
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Middle East & Africa
      • Market Analysis and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Global Neurostimulation Devices Market – Opportunity Analysis Index, By
  2. Application, Product Type, Device Type, End User and Region, 2020 – 2026
  3. North America Neurostimulation Devices Market Analysis 2020 – 2026
    • Application Analysis Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%),
  4. and Market Share (%)
    • Management of Pain
    • Parkinson’s Disease
    • Epilepsy
    • Gastroparesis
    • Tremors
    • Urinary & Fecal Incontinence
    • Depression
    • Dystonia
  • Product Type Analysis Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%),
  1. and Market Share (%)
    • Deep Brain Stimulators (DBS)
    • Gastric Electric Stimulators (GES)
    • Spinal Cord Stimulators (SCS)
    • Sacral Nerve Stimulators (SNS)
    • Vagus Nerve Stimulators (VNS)
  • Device Type Analysis Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%),
  1. and Market Share (%)
    • Invasive Devices
    • Non-Invasive Devices
  • End User Analysis Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and
  1. Market Share (%)
    • Hospitals

Report

Company Profile

  • Key player’s profiles in the global neurostimulation devices market include:

    • Abbott Laboratories (U.S.)
    • Axonics Modulation Technologies, Inc., (U.S.)
    • BioControl Medical (U.S.)
    • Bioness Inc. (U.S.)
    • Biowave Corporation (U.S.)
    • Boston Scientific Corporation (U.S.)
    • Cefaly Technology (Belgium)
    • Cerbomed GmbH (Germany)
    • Cogentix Medical (U.S.)
    • CVRx (U.S.)
    • Enteromedics Inc. (U.S.)
    • Imthera (U.S.)
    • Inspire Medical Systems Inc., (U.S.)
    • LivaNova PLC (U.K.)
    • Mainstay Medical International PLC (Republic of Ireland)
    • Medtronic (U.S.)
    • Neuromod Devices Ltd (Republic of Ireland)
    • Neuropace,Inc., (U.S.)
    • Nevro Corp (U.S.)
    • Novum Therapeutics, Inc. (U.S.)
    • Respicardia, Inc. (U.S.)
    • ScyFIX (U.S.)
    • Soterix Medical Inc (U.S.)
    • SPR Therapeutics (U.S.)
    • Stimwave LLC (U.S.)
    • Synapse Biomedical Inc. (U.S.)
    • Brainsway Ltd (Israel)
    • MMJ Labs (U.S.)
    • Neuronetics (U.S.)
    • Neuronix LTD (Israel)

Description

The global neurostimulation devices market size valued at $5.47 billion in 2021 and expected to reach $10.96 billion in 2028, growing at a CAGR of 11.8% during the forecast period 2022-2028. For the treatment of chronic pain, movement problems, epilepsy, and Parkinson’s disease, neurostimulation devices administer electrical stimulation to specific regions of the patient’s brain, spinal cord, or peripheral nervous system. Spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and cortical stimulators are among the neurostimulation devices. High cost, device malfunctions, and stringent regulatory policies are projected to restrain the growth of the market over the forecast period. For instance, in February 2014, TGA gave hazard alert to Medtronic’s deep brain and spinal cord stimulation systems due to unexpected loss of stimulation and over-stimulation of the devices in the Australia. This report studies neurostimulation devices market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, neurostimulation devices market report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed neuromodulation devices market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX